NASDAQ · HSDT
Financial Services · Asset Management
$2.09▼ 7.52% ($0.17)at close
After hours$2.05▼ 1.91%·7:30 PM ET
Market cap
$122.03M
P/E
N/M
EPS (TTM)
-$2.01
Valuation
A P/E estimate isn't available here
Trailing four-quarter earnings were negative, so a P/E estimate is not meaningful (N/M).
USD · Trailing earnings · Price used $2.09 · Price Oct 30, 8:00 PM UTC
USD · Trailing earnings · Price used $2.09 · Price Oct 30, 8:00 PM UTC
Price vs Fundamentals
The stock fell 65.05% over the last year. Operating margin moved from 5,532.32% to -209.86%.
The market appears to be responding to weaker operating momentum rather than only rerating the stock.
Operating margin stands at -209.86%. If margins stabilize while the stock stays depressed, the gap shifts from fundamental damage toward pure multiple compression.
Company profile
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness.
Market multiples
Stock splits
Every 50 shares became 1
Every 15 shares became 1
Every 50 shares became 1
Every 35 shares became 1
Every 5 shares became 1
Profitability & growth
Standard profitability metrics can be misleading for financial/insurance companies. GAAP requires unrealized investment gains/losses in net income (affecting ROE), and margins are blended across diverse business segments.
Analyst consensus
3
Buy
2
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Actuals vs estimates by quarter, or any quarter against the same one a year earlier.
Next report
Nov 17, 2026
Q3 FY26 · EPS est $0.02 · Revenue est $2.9M
Q2 FY26
Reported Aug 14, 2026 · Latest
HoverTap a quarter to inspect
Actual
-$0.38
Estimate
-$0.02
Year over year
n/m
Vs prior quarter
n/m
2 beats · 2 misses in the last 4 quarters
Solana Company · HSDT
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.
Next earnings
Nov 17, 2026